These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11152014)

  • 1. Can antiarrhythmic agents be selected based on mechanism of action?
    Lau W; Newman D; Dorian P
    Drugs; 2000 Dec; 60(6):1315-28. PubMed ID: 11152014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What a clinician needs to know about the mechanisms of action of antiarrhythmic drugs.
    Janse MJ
    Clin Cardiol; 1991 Jan; 14(1):65-7. PubMed ID: 2019031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of antiarrhythmic drugs.
    Capucci A; Aschieri D; Villani GQ
    Drugs Aging; 1998 Jul; 13(1):51-70. PubMed ID: 9679209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Circulation; 1991 Oct; 84(4):1831-51. PubMed ID: 1717173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on antiarrhythmic drug pharmacology.
    Huang CL; Wu L; Jeevaratnam K; Lei M
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):579-592. PubMed ID: 31930579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Class-I antiarrhythmic drugs].
    Kuga K; Sugishita Y
    Nihon Rinsho; 1996 Aug; 54(8):2110-6. PubMed ID: 8810785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classifying antiarrhythmic actions: by facts or speculation.
    Vaughan Williams EM
    J Clin Pharmacol; 1992 Nov; 32(11):964-77. PubMed ID: 1474169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM Trial. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ; Mann DE; Reiffel JE; Hahn E; Hartz V
    Circulation; 1995 Apr; 91(7):1988-95. PubMed ID: 7895357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators.
    Wyse DG; Morganroth J; Ledingham R; Denes P; Hallstrom A; Mitchell LB; Epstein AE; Woosley RL; Capone R
    J Am Coll Cardiol; 1994 Apr; 23(5):1130-40. PubMed ID: 8144779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antiarrhythmic agents for ventricular arrhythmias.
    Meissner MD; Nestico PF; Morganroth J
    Clin Ther; 1986; 8(6):595-604. PubMed ID: 3539346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic evaluation of antiarrhythmic drugs.
    Touboul P
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():535-9. PubMed ID: 2275885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos.
    Katritsis D; Camm AJ
    Clin Cardiol; 1994 Mar; 17(3):142-8. PubMed ID: 7513270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha D
    Am J Cardiol; 1997 Oct; 80(8A):16G-23G. PubMed ID: 9354408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.